At the 2024 Annual Meeting, Galectin Therapeutics' stockholders elected directors and ratified Cherry Bekaert LLP as the independent auditor for 2024, with significant support for all nominees and the auditor selection.
AI Assistant
GALECTIN THERAPEUTICS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.